iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7‐Dependent Pathway-Reference-Cited by-同舟云学术

iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7‐Dependent Pathway

Published:2021-04 Issue:4 Volume:73 Page:1346-1364
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Xu Minxuan¹²³,Ge Chenxu¹²³,Zhu Liancai²,Qin Yuting⁴,Du Chengjiang⁵,Lou Deshuai¹³,Li Qiang¹³,Hu Linfeng¹³,Sun Yan¹,Dai Xianling¹,Xiong Mingxin¹,Long Tingting¹,Zhan Jianxia¹,Kuang Qin¹,Li Huanhuan¹,Yang Qiufeng¹,Huang Ping⁶,Teng Xuepeng⁷,Feng Jing¹³,Wu Yekuan¹³,Dong Wei⁷,Wang Bochu²,Tan Jun¹³

Affiliation:

1. Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region School of Biological and Chemical Engineering Chongqing University of Education Chongqing China

2. Key Laboratory of Biorheological Science and Technology (Chongqing University) Ministry of Education College of Bioengineering Chongqing University Chongqing China

3. Research Center of Brain Intellectual Promotion and Development for Children Aged 0‐6 Years Chongqing University of Education Chongqing China

4. School of Medicine and Pharmacy Ocean University of China Qingdao China

5. Department of Hepatobiliary Surgery Linyi People's Hospital Linyi, Shandong China

6. Department Hepatobiliary Surgery The First Affiliated Hospital of Chongqing Medical University Chongqing China

7. Department of Oncology Shandong Cancer Hospital and InstituteShandong First Medical University & Shandong Academy of Medical Sciences Jinan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31436

Reference19 articles.

1. Obesity, inflammation, and the gut microbiota

2. Adipose Natural Killer Cells Regulate Adipose Tissue Macrophages to Promote Insulin Resistance in Obesity

3. Obesity and cardiovascular outcomes: a review

4. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

5. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP13 ameliorates nonalcoholic fatty liver disease through inhibiting the activation of TAK1;Journal of Translational Medicine;2024-07-20

2. E3 ubiquitin ligase TRIM31: A potential therapeutic target;Biomedicine & Pharmacotherapy;2024-07

3. Identification of key genes involved in the alleviative effects of Polysaccharide of Atractylodes macrocephala Koidz on high-fat diet-induced nonalcoholic fatty liver disease in mice;Journal of Functional Foods;2024-05

4. Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease;Lipids in Health and Disease;2024-02-17

5. Altered splicing factor and alternative splicing events in a mouse model of diet- and polychlorinated biphenyl-induced liver disease;Environmental Toxicology and Pharmacology;2023-10